Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea
NCT00328965
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Essential Hypertension
Interventions
DRUG:
Lacidipine
Sponsor
GlaxoSmithKline